Participating in a vaccine trial for COVID-19 in Senegal: trust and information

This research aims to understand the level and determinants of people's willingness to participate in a vaccine trial for COVID-19 in Senegal. We conducted a telephone survey among a marginal quota sample of 607 people over 18 years of age. Only 44.3% of the participants wanted to participate in a vaccine trial for COVID-19, with females intending to participate more than males (AOR = 1.82, 95% CI [1.22-2.72]). Participants who intended to be vaccinated against COVID-19 (AOR = 6.48, 95% CI [4.12-10.4]) and who thought that being infected with the coronavirus would have a significant impact on their health (AOR = 2.34, 95% CI [1.57, 3.51]) were more likely to agree to take part in the COVID-19 vaccine trial. Confidence in the vaccine, health personnel, and the government in the fight against the pandemic are key factors in participants' willingness to participate in a vaccine trial in Senegal.

Automated summary

The willingness of Senegalese people to participate in a COVID-19 vaccine trial is not high, with females showing a higher intention. Those who are willing to receive the COVID-19 vaccine and believe that getting infected with the coronavirus would have a significant impact on their health are more likely to agree to participate. Confidence in the vaccine, health personnel, and government plays a crucial role in determining participants' willingness to join the vaccine trial.